The balance between two isoforms of LEF-1 regulates colon carcinoma growth

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Wang, Shu Hong ^a   Nan, Ke Jun ^a   Wang, Yao Chun ^b   Wang, Wen Juan ^a   Tian, Tao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CHEMOKINE RECEPTOR CXCR4; ISOPROTEIN; LIPOCORTIN 5; LYMPHOID ENHANCER FACTOR 1; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GROWTH; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICE, NUDE; PHENOTYPE; PROTEIN ISOFORMS; RECEPTORS, CXCR4; TRANSPLANTATION, HETEROLOGOUS; WNT PROTEINS;

EID: 84861433631     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-53     Document Type: Article

References (33)

1. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480. 10.1016/j.cell.2006.10.018, 17081971.
2. Giese K, Amsterdam A, Grosschedl R. DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev 1991, 5:267-278.
3. Bruhn L, Munnerlyn A, Grosschedl R. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev 1997, 11:640-653. 10.1101/gad.11.5.640, 9119228.
4. Hsu SC, Galceran J, Grosschedl R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 1998, 18:4807-4818. 109066, 9671490.
5. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature 2005, 434:843-850. 10.1038/nature03319, 15829953.
6. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007, 128:445-458. 10.1016/j.cell.2007.01.014, 2408375, 17289566.
7. Li TW, Ting JH, Yokoyama NN, Bernstein A, van de Wetering M, Waterman ML. Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Bio 2006, 26:5284-5299.
8. Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, Engelhardt JF, Amendt BA. PITX2 and beta-catenin interactions regulate Lef-1 isoform expression. Mol Cell Bio 2007, 27:7560-7573.
9. Hovanes K, Li TW, Waterman ML. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 2000, 28:1994-2003. 10.1093/nar/28.9.1994, 103301, 10756202.
10. Jimenez J, Jang GM, Semler BL, Waterman ML. An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA 2005, 11:1385-1399. 10.1261/rna.7226105, 1370822, 16120831.
11. van de Wetering M, Castrop J, Korinek V, Clevers H. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol Cell Biol 1996, 16:745-752. 231054, 8622675.
12. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 2001, 28:53-57.
13. Porfiri E, Rubinfeld B, Albert I, Hovanes K, Waterman M, Polakis P. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene 1997, 15:2833-2839. 10.1038/sj.onc.1201462, 9419974.
14. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319. 10.1038/nprot.2006.339, 17406473.
15. Hu XB, Feng F, Wang YC, Wang L, He F, Dou GR, Liang L, Zhang HM, Liang YM, Han H. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009, 11:32-38. 2606116, 19107229.
16. Reya T, O'Riordan M, Okamura R. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 2000, 13:15-24. 10.1016/S1074-7613(00)00004-2, 10933391.
17. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 2007, 109:4753-4760. 10.1182/blood-2006-12-063933, 1885521, 17311993.
18. Staal FJ, Clevers HC. WNT signaling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 2005, 5:21-30. 10.1038/nri1529, 15630426.
19. Okamura RM, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. Redundant regulation of T cell diff erentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 1998, 8:11-20. 10.1016/S1074-7613(00)80454-9, 9462507.
20. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
21. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Nat. Acad Sci USA 1999, 96:5522-5527. 10.1073/pnas.96.10.5522, 21892, 10318916.
22. Floege J, Smeets B, Moeller MJ. The SDF-1/CXCR4 axis is a novel driver of vascular development of the glomerulus. J Am Soc Nephrol 2009, 8:1714-1723.
23. Shen X, Wang S, Wang H, Liang M, Xiao L, Wang Z. The role of SDF-1/CXCR4 axis in ovarian cancer metastasis. J Huazhong Univ Sci Technol Med Sci 2009, 29:363-367. 10.1007/s11596-009-0320-0, 19513623.
24. Liu F, Lang R, Wei J, Fan Y, Cui L, Gu F, Guo X, Pringle GA, Zhang X, Fu L. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology 2009, 54:741-750. 10.1111/j.1365-2559.2009.03289.x, 19438749.
25. Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res 2009, 104:1293-1301. 10.1161/CIRCRESAHA.109.197533, 2757744, 19423843.
26. Otsuka S, Bebb G. The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer. J Thorac Oncol 2008, 3:1379-1383. 10.1097/JTO.0b013e31818dda9d, 19057260.
27. Luo Y, Cai J, Xue H, Mattson MP, Rao MS. SDF1α/CXCR4 signaling stimulates β-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 2006, 398:291-295. 10.1016/j.neulet.2006.01.024, 16469439.
28. Wang Z, Ma Q. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 2007, 69:816-820. 10.1016/j.mehy.2007.01.069, 17379424.
29. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321. 10.1378/chest.06-2568, 17934117.
30. Liu Z, Habener JF. Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2). Diabetologia 2009, 52:1589-1598. 10.1007/s00125-009-1384-x, 19468708.
31. Aman A, Piotrowski T. Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. Dev Cell 2008, 15:749-761. 10.1016/j.devcel.2008.10.002, 19000839.
32. Wang Z, Ma Q, Liu Q, et al. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br J Cancer 2008, 99:1695-1703. 10.1038/sj.bjc.6604745, 2584946, 19002187.
33. Samara GJ, Lawrence DM, Chiarelli CJ, Valentino MD, Lyubsky S, Zucker S, Vaday GG. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 2004, 214:231-241. 10.1016/j.canlet.2004.04.035, 15363550.